Illumina, Inc. vs JetBlue Airways Corporation — how do they compare? Illumina, Inc. trades at $184.68 (market cap $27.94B), while JetBlue Airways Corporation trades at $5.34 (market cap $2.03B). The key difference: Illumina, Inc. is far larger — about 13.8× JetBlue Airways Corporation's market cap, and Illumina, Inc. is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.
| ILMN | JBLU | |
|---|---|---|
Market Cap | $27.94B | $2.03B |
Sector | Health | Industrials |
52-Week High | $194.33 | $6.46 |
52-Week Low | $91.00 | $4.03 |
Enterprise Value | $29.33B | $9.19B |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →